TD
Thomas Desrosier
DELAYED 1 MONTH
EVP and Chief Legal Officer
Seres Therapeutics, Inc.
Filings
2
Companies
1
Latest
May 15, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
67
MCRBCLUSTER 4
Seres Therapeutics, Inc.
Thomas Desrosier
EVP and Chief Legal Officer
Sale
$595
79 sh
May 19 8:05 PM
May 18, 2026
—
Seres Therapeutics, Inc.
Thomas Desrosier
EVP and Chief Legal Officer
Option Exercise
—
244 sh
May 19 8:05 PM
May 15, 2026